JP2021525618A - インターフェースを備えた携帯型痒み治療デバイス - Google Patents
インターフェースを備えた携帯型痒み治療デバイス Download PDFInfo
- Publication number
- JP2021525618A JP2021525618A JP2020568470A JP2020568470A JP2021525618A JP 2021525618 A JP2021525618 A JP 2021525618A JP 2020568470 A JP2020568470 A JP 2020568470A JP 2020568470 A JP2020568470 A JP 2020568470A JP 2021525618 A JP2021525618 A JP 2021525618A
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- temperature
- interface
- portable device
- portable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 84
- 238000011282 treatment Methods 0.000 title claims description 373
- 238000010438 heat treatment Methods 0.000 claims abstract description 136
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 92
- 238000004146 energy storage Methods 0.000 claims description 13
- 229910052744 lithium Inorganic materials 0.000 claims description 9
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 8
- 238000005259 measurement Methods 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 4
- 229910052987 metal hydride Inorganic materials 0.000 claims description 3
- 206010020843 Hyperthermia Diseases 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- 230000036031 hyperthermia Effects 0.000 claims description 2
- 150000004681 metal hydrides Chemical class 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000007669 thermal treatment Methods 0.000 abstract description 16
- 230000007803 itching Effects 0.000 description 61
- 210000003491 skin Anatomy 0.000 description 49
- 230000005540 biological transmission Effects 0.000 description 30
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 23
- 238000012546 transfer Methods 0.000 description 19
- 230000035807 sensation Effects 0.000 description 17
- 208000006877 Insect Bites and Stings Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000001419 dependent effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 9
- 230000007257 malfunction Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 238000013021 overheating Methods 0.000 description 9
- 230000001960 triggered effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 230000001976 improved effect Effects 0.000 description 8
- 102000003565 TRPV2 Human genes 0.000 description 7
- 101150077905 Trpv2 gene Proteins 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 230000000873 masking effect Effects 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 102000003566 TRPV1 Human genes 0.000 description 6
- 101150016206 Trpv1 gene Proteins 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 239000003990 capacitor Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 210000000929 nociceptor Anatomy 0.000 description 5
- 230000008058 pain sensation Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 206010003399 Arthropod bite Diseases 0.000 description 4
- 206010003402 Arthropod sting Diseases 0.000 description 4
- 241000255925 Diptera Species 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000005923 long-lasting effect Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 3
- 241000243321 Cnidaria Species 0.000 description 3
- 102000011040 TRPV Cation Channels Human genes 0.000 description 3
- 108010062740 TRPV Cation Channels Proteins 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000001640 nerve ending Anatomy 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 108091008700 nociceptors Proteins 0.000 description 3
- 230000008447 perception Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000021317 sensory perception Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000003014 Bites and Stings Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010016334 Feeling hot Diseases 0.000 description 2
- 208000004898 Herpes Labialis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 206010028347 Muscle twitching Diseases 0.000 description 2
- 206010067152 Oral herpes Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000009108 Urtica dioica Nutrition 0.000 description 2
- 241000218215 Urticaceae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 108091008708 free nerve endings Proteins 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- GELKBWJHTRAYNV-UHFFFAOYSA-K lithium iron phosphate Chemical compound [Li+].[Fe+2].[O-]P([O-])([O-])=O GELKBWJHTRAYNV-UHFFFAOYSA-K 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- 230000006855 networking Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 101000924591 Apis mellifera Apamin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000033999 Device damage Diseases 0.000 description 1
- 101100127285 Drosophila melanogaster unc-104 gene Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 101000738322 Homo sapiens Prothymosin alpha Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- -1 Nickel metal hydride Chemical class 0.000 description 1
- 102100024304 Protachykinin-1 Human genes 0.000 description 1
- 102100037925 Prothymosin alpha Human genes 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
- 102000001400 Tryptase Human genes 0.000 description 1
- 108060005989 Tryptase Proteins 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010053510 Venomous sting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- ZRXYMHTYEQQBLN-UHFFFAOYSA-N [Br].[Zn] Chemical compound [Br].[Zn] ZRXYMHTYEQQBLN-UHFFFAOYSA-N 0.000 description 1
- BPKGOZPBGXJDEP-UHFFFAOYSA-N [C].[Zn] Chemical compound [C].[Zn] BPKGOZPBGXJDEP-UHFFFAOYSA-N 0.000 description 1
- KLARSDUHONHPRF-UHFFFAOYSA-N [Li].[Mn] Chemical compound [Li].[Mn] KLARSDUHONHPRF-UHFFFAOYSA-N 0.000 description 1
- JDZCKJOXGCMJGS-UHFFFAOYSA-N [Li].[S] Chemical compound [Li].[S] JDZCKJOXGCMJGS-UHFFFAOYSA-N 0.000 description 1
- LTDAQVLIZRQEBW-UHFFFAOYSA-N [Li].[S].[Sn] Chemical compound [Li].[S].[Sn] LTDAQVLIZRQEBW-UHFFFAOYSA-N 0.000 description 1
- TWLBWHPWXLPSNU-UHFFFAOYSA-L [Na].[Cl-].[Cl-].[Ni++] Chemical compound [Na].[Cl-].[Cl-].[Ni++] TWLBWHPWXLPSNU-UHFFFAOYSA-L 0.000 description 1
- BNOODXBBXFZASF-UHFFFAOYSA-N [Na].[S] Chemical compound [Na].[S] BNOODXBBXFZASF-UHFFFAOYSA-N 0.000 description 1
- DUCFBDUJLLKKPR-UHFFFAOYSA-N [O--].[Zn++].[Ag+] Chemical compound [O--].[Zn++].[Ag+] DUCFBDUJLLKKPR-UHFFFAOYSA-N 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 1
- 229940046731 calcineurin inhibitors Drugs 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000012983 electrochemical energy storage Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000000802 evaporation-induced self-assembly Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002919 insect venom Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UGKDIUIOSMUOAW-UHFFFAOYSA-N iron nickel Chemical compound [Fe].[Ni] UGKDIUIOSMUOAW-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- BFZPBUKRYWOWDV-UHFFFAOYSA-N lithium;oxido(oxo)cobalt Chemical compound [Li+].[O-][Co]=O BFZPBUKRYWOWDV-UHFFFAOYSA-N 0.000 description 1
- LWRYTNDOEJYQME-UHFFFAOYSA-N lithium;sulfanylideneiron Chemical compound [Li].[Fe]=S LWRYTNDOEJYQME-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- WJZHMLNIAZSFDO-UHFFFAOYSA-N manganese zinc Chemical compound [Mn].[Zn] WJZHMLNIAZSFDO-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- YVIIHEKJCKCXOB-STYWVVQQSA-N molport-023-276-178 Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(N[C@@H](CSSC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)=O)CC(C)C)[C@@H](C)O)C(N)=O)C1=CNC=N1 YVIIHEKJCKCXOB-STYWVVQQSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QELJHCBNGDEXLD-UHFFFAOYSA-N nickel zinc Chemical compound [Ni].[Zn] QELJHCBNGDEXLD-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000003370 receptor cell Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 231100001068 severe skin irritation Toxicity 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- BSWGGJHLVUUXTL-UHFFFAOYSA-N silver zinc Chemical compound [Zn].[Ag] BSWGGJHLVUUXTL-UHFFFAOYSA-N 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000003238 somatosensory effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 208000037911 visceral disease Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- UJNIPSOPFYWLEN-UHFFFAOYSA-N zinc mercury(1+) oxygen(2-) Chemical compound [Hg+].[O-2].[Zn+2] UJNIPSOPFYWLEN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/30—Services specially adapted for particular environments, situations or purposes
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/70—Services for machine-to-machine communication [M2M] or machine type communication [MTC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
- A61F2007/0077—Details of power supply
- A61F2007/0078—Details of power supply with a battery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
- A61F2007/0077—Details of power supply
- A61F2007/0078—Details of power supply with a battery
- A61F2007/008—Details of power supply with a battery with a separate, portable battery pack
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0093—Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0094—Heating or cooling appliances for medical or therapeutic treatment of the human body using a remote control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
- A61F2007/0096—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
- A61F2007/0284—Treatment of stings or bites
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Signal Processing (AREA)
- Computer Networks & Wireless Communication (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Description
Claims (15)
- 少なくとも1つの加熱素子を加熱することによって40℃〜65℃の治療温度まで加熱することができ、制御デバイスによって制御することができる少なくとも1つの治療表面を備える、痒みの温熱治療用デバイスであって、
前記デバイスが、少なくとも1つのインターフェースを示し、前記インターフェースを介した携帯型デバイスによる前記デバイスへの電力供給用及び/又は携帯型デバイスとのデータ交換用及び/又は携帯型デバイスによる制御用に構成されることを特徴とする、デバイス。 - 前記デバイスが前記制御デバイスを備えることを特徴とする、請求項1に記載のデバイス。
- 前記デバイスが、前記携帯型デバイスによって前記制御デバイスをパラメータ化するように構成されることを特徴とする、請求項2に記載のデバイス。
- 前記デバイスが、前記携帯型デバイスによって前記制御デバイスの制御プログラムを送信するように構成されることを特徴とする、請求項2又は3に記載のデバイス。
- 前記携帯型デバイスが前記制御デバイスを含むことを特徴とする、請求項1に記載のデバイス。
- 前記インターフェースを介した前記携帯型デバイスによる前記デバイスの前記電力供給、及び/又は前記携帯型デバイスとの前記データ交換、及び/又は前記携帯型デバイスによる前記制御が無線であることを特徴とする、請求項1から5までのいずれか一項又は複数項に記載のデバイス。
- 前記治療温度が40℃〜60℃であり、前記治療表面のサイズが1cm2〜18cm2であることを特徴とする、請求項1から6までのいずれか一項又は複数項に記載のデバイス。
- 前記治療温度が40℃〜60℃であり、前記治療表面のサイズが1cm2未満であることを特徴とする、請求項1から7までのいずれか一項又は複数項に記載のデバイス。
- 前記デバイスが、エネルギー貯蔵部、好ましくはアキュムレータ、特に好ましくはリチウム・ポリマー・アキュムレータ及び/又は金属水素化物アキュムレータを備えることを特徴とする、請求項1から8までのいずれか一項又は複数項に記載のデバイス。
- 前記アキュムレータが、固体アキュムレータ、好ましくはリチウム・セラミック・アキュムレータである、請求項9に記載のデバイス。
- 前記デバイスが、前記治療表面の温度を測定する少なくとも1つの第1の温度センサを備え、調整デバイス及び/又は制御デバイスが、前記温度センサの測定データに基づいて、前記少なくとも1つの加熱素子の温度を調節することを特徴とする、請求項1から10までのいずれか一項又は複数項に記載のデバイス。
- 治療温度が1〜10秒間の治療持続時間にわたって維持される、請求項1から11までのいずれか一項又は複数項に記載のデバイス。
- ハードウェア実装温度モニタが前記治療表面の最高温度を可逆的に制限し、ヒューズが、短絡回路又は制御されない連続加熱の場合に前記デバイスを停止する、請求項1から12までのいずれか一項又は複数項に記載のデバイス。
- 前記ハードウェア実装温度モニタが、前記治療表面の温度を測定する少なくとも第2の温度センサと、比較器とを備え、前記比較器が前記治療表面の温度を前記最高温度と比較し、前記最高温度を超えている場合、前記加熱素子への前記電流供給を遮断する、請求項13に記載のデバイス。
- デバイスが、インターフェースを介した携帯型デバイスによる電力供給用及び/又は前記携帯型デバイスとのデータ交換用及び/又は前記携帯型デバイスによる制御用に構成される、デバイスと携帯型デバイスとを備えるシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18176545.4A EP3578146A1 (de) | 2018-06-07 | 2018-06-07 | Mobile vorrichtung zur behandlung von juckreiz mit schnittstelle |
EP18176545.4 | 2018-06-07 | ||
PCT/EP2019/064817 WO2019234172A1 (de) | 2018-06-07 | 2019-06-06 | Mobile vorrichtung zur behandlung von juckreiz mit schnittstelle |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021525618A true JP2021525618A (ja) | 2021-09-27 |
Family
ID=62567458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020568470A Pending JP2021525618A (ja) | 2018-06-07 | 2019-06-06 | インターフェースを備えた携帯型痒み治療デバイス |
Country Status (9)
Country | Link |
---|---|
US (1) | US20210236327A1 (ja) |
EP (2) | EP3578146A1 (ja) |
JP (1) | JP2021525618A (ja) |
KR (1) | KR20210018891A (ja) |
CN (1) | CN112533562A (ja) |
AU (1) | AU2019283424A1 (ja) |
CA (1) | CA3102351A1 (ja) |
IL (1) | IL279211A (ja) |
WO (1) | WO2019234172A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102017006994A1 (de) * | 2017-07-24 | 2019-01-24 | Stefan Hotz | Koppelbare portable Vorrichtung zur thermisch - medizinischen Behandlung der Haut |
CN111771840A (zh) * | 2020-07-07 | 2020-10-16 | 时光科技(中山)有限公司 | 多功能灭蚊器 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010008974A1 (en) * | 1993-10-04 | 2001-07-19 | Huan-Chen Li | Method and apparatus for treatment of skin itch and disease |
JP2008540050A (ja) * | 2005-05-18 | 2008-11-20 | タイレル、インク | 熱を印加して皮膚病変を治療するための治療装置および方法 |
KR101722904B1 (ko) * | 2016-08-24 | 2017-04-05 | 고재정 | 휴대용 해충 물림 진정기구 |
CN107455859A (zh) * | 2017-08-01 | 2017-12-12 | 无锡南理工科技发展有限公司 | 可穿戴的止痒手环 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245093B1 (en) * | 1993-10-04 | 2001-06-12 | Huan-Chen Li | Method and apparatus for treatment of skin itch and disease |
DE19954424A1 (de) | 1999-11-11 | 2001-06-07 | Hansgeorg Schuldzig | Einrichtung zur lokalen thermischen Behandlung von Insektenstichen und -bissen |
DE102005002946A1 (de) | 2005-01-18 | 2006-07-27 | Bsm - Bionic Solution Management Gmbh | Herpesbehandlungseinrichtung |
US20090306748A1 (en) * | 2008-06-04 | 2009-12-10 | The Research Foundation Of State University Of New York | Body thermal regulation/measurement system |
US8143559B2 (en) * | 2009-09-01 | 2012-03-27 | Advance Thermo Control, Ltd. | Heating pad with temperature control and safety protection device |
EP2528559A1 (en) | 2010-01-27 | 2012-12-05 | Bruder Healthcare Company | Heating element with thermal fuse |
US10603208B2 (en) * | 2011-01-21 | 2020-03-31 | Carewave Medical, Inc. | Modular stimulus applicator system and method |
CA2937547A1 (en) * | 2014-01-22 | 2015-07-30 | Ekaabo Inc. | Portable device for treating external boils |
US20170273821A1 (en) * | 2016-03-22 | 2017-09-28 | Elc Management Llc | Array Of Cutaneous Patches For Delivery And Heating Of Personal Care Products |
CN109561984B (zh) * | 2016-08-05 | 2022-08-05 | 皇家飞利浦有限公司 | 热皮肤处理设备 |
US9795502B1 (en) * | 2016-09-08 | 2017-10-24 | Tiberiu Kopes | Controllable heated mask |
DK3308752T3 (da) * | 2016-10-11 | 2020-06-22 | Dermapharm Ag | Indretning til hyperthermisk behandling af kløe |
US10406024B2 (en) * | 2016-11-29 | 2019-09-10 | RecoverX, Inc. | Wearable temperature therapy system and method |
US10257885B2 (en) * | 2017-06-08 | 2019-04-09 | Carmming International | Energy-saving heating wearable apparatus |
DE102017006994A1 (de) * | 2017-07-24 | 2019-01-24 | Stefan Hotz | Koppelbare portable Vorrichtung zur thermisch - medizinischen Behandlung der Haut |
-
2018
- 2018-06-07 EP EP18176545.4A patent/EP3578146A1/de not_active Withdrawn
-
2019
- 2019-06-06 CA CA3102351A patent/CA3102351A1/en active Pending
- 2019-06-06 WO PCT/EP2019/064817 patent/WO2019234172A1/de unknown
- 2019-06-06 CN CN201980052117.5A patent/CN112533562A/zh active Pending
- 2019-06-06 JP JP2020568470A patent/JP2021525618A/ja active Pending
- 2019-06-06 EP EP19729518.1A patent/EP3801413A1/de active Pending
- 2019-06-06 AU AU2019283424A patent/AU2019283424A1/en not_active Abandoned
- 2019-06-06 US US15/734,730 patent/US20210236327A1/en active Pending
- 2019-06-06 KR KR1020217000001A patent/KR20210018891A/ko not_active Application Discontinuation
-
2020
- 2020-12-03 IL IL279211A patent/IL279211A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010008974A1 (en) * | 1993-10-04 | 2001-07-19 | Huan-Chen Li | Method and apparatus for treatment of skin itch and disease |
JP2008540050A (ja) * | 2005-05-18 | 2008-11-20 | タイレル、インク | 熱を印加して皮膚病変を治療するための治療装置および方法 |
KR101722904B1 (ko) * | 2016-08-24 | 2017-04-05 | 고재정 | 휴대용 해충 물림 진정기구 |
CN107455859A (zh) * | 2017-08-01 | 2017-12-12 | 无锡南理工科技发展有限公司 | 可穿戴的止痒手环 |
Also Published As
Publication number | Publication date |
---|---|
KR20210018891A (ko) | 2021-02-18 |
AU2019283424A1 (en) | 2021-01-21 |
WO2019234172A1 (de) | 2019-12-12 |
EP3578146A1 (de) | 2019-12-11 |
CN112533562A (zh) | 2021-03-19 |
US20210236327A1 (en) | 2021-08-05 |
CA3102351A1 (en) | 2019-12-12 |
EP3801413A1 (de) | 2021-04-14 |
IL279211A (en) | 2021-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI772314B (zh) | 用於瘙癢症的高熱治療之裝置 | |
KR101949543B1 (ko) | 모듈형 자극 인가 시스템 및 방법 | |
JP2021525618A (ja) | インターフェースを備えた携帯型痒み治療デバイス | |
KR20200032697A (ko) | 피부의 열-의학적 처치를 위한 결합 가능 휴대 장치 | |
US20220142813A1 (en) | Mobile itching treatment device with interface | |
EA037168B1 (ru) | Устройство для гипертермического лечения зуда | |
US20220218514A1 (en) | Ophthalmic devices, systems and methods for treating dry eye | |
ES2935492T3 (es) | Dispositivo con un sensor de contacto para el tratamiento de comezón y enfermedades por herpes | |
CN204562881U (zh) | 一种艾灸治疗仪控制电路 | |
KR102578230B1 (ko) | 휴대용 복합 자극 장치 | |
CN105582614A (zh) | 一种简易的app控制的可穿戴便携式脉冲止汗仪及使用方法 | |
KR20210065469A (ko) | 충전식 무선 보온 저주파 자극기 | |
EA040683B1 (ru) | Устройство для гипертермического лечения прурита |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220523 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230214 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230215 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230512 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230712 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230914 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240205 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240502 |